Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
about
Genetics and genomics of radiotherapy toxicity: towards predictionSequencing and analysis of a South Asian-Indian personal genomeMolecular mechanism of action of metformin: old or new insights?Five years of GWAS discoveryPharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agentsPersonalized medicine in diabetes: the role of 'omics' and biomarkersAtaxia-telangiectasia: future prospectsPharmacogenomics discovery and implementation in genome-wide association studies eraCellular and molecular mechanisms of metformin: an overviewPathogenesis of ataxia-telangiectasia: the next generation of ATM functionsThe role of the p53 tumor suppressor in metabolism and diabetesPharmacogenomics in diabetes mellitus: insights into drug action and drug discoveryMetformin in obesity, cancer and aging: addressing controversiesAlterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metforminPersonalized medicine in Type 2 DiabetesGenomic Characterization of Metformin Hepatic ResponseBiomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approachStratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases.AMPK: a nutrient and energy sensor that maintains energy homeostasisPharmacogenomics in type 2 diabetes: oral antidiabetic drugs.Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.PUMA: a unified framework for penalized multiple regression analysis of GWAS dataGenetics of type 2 diabetes: insights into the pathogenesis and its clinical application.Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.Innate immune activity conditions the effect of regulatory variants upon monocyte gene expressionThe role of genetic factors and kidney and liver function in glycemic control in type 2 diabetes patients on long-term metformin and sulphonylurea cotreatment.Metformin pharmacogenomics: current status and future directions.Metformin pharmacogenomics: biomarkers to mechanisms.Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.An update on the pharmacogenomics of metformin: progress, problems and potential.Signal transduction by mitochondrial oxidants.Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.LDGIdb: a database of gene interactions inferred from long-range strong linkage disequilibrium between pairs of SNPs.Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.ATM signalling and cancer.Genomics: Drugs, diabetes and cancerGenetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish populationPatient profiling in diabetes and role of canagliflozin.
P2860
Q21183971-803AFB13-1E69-4B56-AC30-8914B2829FB3Q21266697-D655027B-BD11-447F-8D0C-6C837CA27706Q22252798-E51E2629-E66C-4B45-B34D-5B12E4D73F6CQ24610574-196F7C47-4097-4A4C-BD3D-AB5976AC3EBAQ26751138-0EBC34B6-19AF-4774-BA4D-1E2DC0BA7C74Q26775259-7CA5ED91-DF2D-4D69-A032-85B3EB664009Q26863728-3073B8E1-4451-4AFB-9EFB-D7255DE0DCA9Q27001573-47387966-916B-409B-87DA-F6A25F6477AFQ27013561-27114692-1FD5-4004-89A2-B23ADC8B3707Q27025786-60F1D51F-03D3-4F68-89D1-B6DA10FD3039Q28079903-A47D7D0E-228C-424D-9271-7FD26D575FD5Q28274686-0990EC49-B629-4B36-BA28-8DB22330FD36Q28480735-64816981-6328-45F6-9EDD-F5C58F9AE89DQ28485299-9B0C5090-9098-4B58-B470-39B29B4A51AEQ28542708-BE9ABDBD-7696-4682-BB01-0DA582130E69Q28554592-6C0A9C0E-14F2-4645-8686-50B6B619EDD6Q28661494-2A14206E-73EA-45EE-AA2E-3401A5C6200EQ29417103-812B547F-7C1A-4A29-AA7F-CE2D5CE6EA02Q29615410-CC20CE95-EDE4-4EA9-8F23-7FFD17DC8FBEQ30248914-1AB547B7-6E39-4767-950A-E301DDE7E677Q30388214-CE1FFE71-9351-4B1A-AAC6-869CA57C31B1Q30407583-AA99F142-CCFF-4D01-BC60-7158BE5541CDQ30571118-D6F8E987-07C8-4829-AEE6-F11556910D90Q30653367-C63336B3-6561-4318-B305-48EF3CFA1054Q33593963-8BAC2C5D-24CF-4B74-A2F5-6A613F29127FQ33686783-6B552DF5-A798-4BB6-BD70-2C361920D331Q33783132-E224E50E-7A2A-4A81-A983-C41D43BED51BQ33804241-EC6BC942-DB57-49B2-8239-0AF26C3CA854Q33959731-A65D2851-1B35-496C-B294-0BB51EE0AB7EQ33959783-F07A0617-9E0F-4E1A-A42E-866EE3D1C334Q33993320-17893C5D-3CA3-48E8-B66A-862EFBCC9963Q34003050-254BF7EE-414D-4BC4-9EDC-43B49B2C921FQ34207242-F2189531-E20A-4D73-A9B6-338824E829D3Q34224429-ACE5D96B-811F-47F2-913E-0A2B3F5B07E6Q34253535-A796A2CF-F134-4334-ABF8-D908E9428135Q34314416-FB379773-0A71-4509-B248-34745A0CBEDEQ34357377-56D3EE2B-F8B7-43DF-BBDD-D17A6EC333C7Q34541943-F0187364-45FA-4EFF-AA86-8149ECF8D28DQ34640398-8F0E5DCA-5F83-4A86-A8C6-D15128329B06Q34729268-D4D8DD04-B281-4335-B7F3-63C5FD505367
P2860
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Common variants near ATM are a ...... o metformin in type 2 diabetes
@ast
Common variants near ATM are a ...... o metformin in type 2 diabetes
@en
Common variants near ATM are a ...... o metformin in type 2 diabetes
@nl
type
label
Common variants near ATM are a ...... o metformin in type 2 diabetes
@ast
Common variants near ATM are a ...... o metformin in type 2 diabetes
@en
Common variants near ATM are a ...... o metformin in type 2 diabetes
@nl
prefLabel
Common variants near ATM are a ...... o metformin in type 2 diabetes
@ast
Common variants near ATM are a ...... o metformin in type 2 diabetes
@en
Common variants near ATM are a ...... o metformin in type 2 diabetes
@nl
P2093
P2860
P50
P356
P1433
P1476
Common variants near ATM are a ...... o metformin in type 2 diabetes
@en
P2093
Alex S F Doney
Amy Strange
Ananth C Viswanathan
Andrew D Morris
Anna Rautanen
Audrey Duncanson
Celine Bellenguez
Chris C A Spencer
Chris Schofield
Christopher J Groves
P2860
P2888
P304
P356
10.1038/NG.735
P407
P50
P577
2010-12-26T00:00:00Z